Skip to content

Hysterectomy With Adnexal Surgery Procedures With the DEXTER Robotic System (The HYPER Study)

Hysterectomy With Adnexal Surgery Procedures With the DEXTER Robotic System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06473675
Enrollment
52
Registered
2024-06-25
Start date
2024-06-20
Completion date
2025-04-02
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysterectomy

Brief summary

This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing robotic-assisted and laparoscopic hysterectomy with adnexal surgery for benign disease.

Interventions

PROCEDUREHysterectomy with adnexal surgery

Robotic-assisted and laparoscopic hysterectomy with adnexal surgery for benign disease.

Sponsors

Distalmotion SA
Lead SponsorINDUSTRY
Confinis
CollaboratorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged \> 18 years * Patients planned to undergo elective robot-assisted and laparoscopic hysterectomy with adnexal surgery for benign disease; using one camera port, two ports for the manipulating instruments, and additional ports as needed.

Exclusion criteria

* Morbidly obese patients (BMI \> 40) * Any relative and absolute contraindications for the use of conventional endoscopes and endoscopic surgical instruments * Need for robotic stapling, advanced energy delivery, ultrasound, cryoablation and microwave energy delivery * Bleeding diathesis * Pregnancy * Patients with pacemakers or internal defibrillators * Any planned concomitant procedures * Patient deprived of liberty by administrative or judicial decision. * Participation in another interventional clinical trial

Design outcomes

Primary

MeasureTime frameDescription
primary safety endpointup to 42 daysoccurrence of Clavien - Dindo grades III-V adverse events
primary performance endpointintraoperativesuccessful completion of the Dexter-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach

Countries

France, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026